Medications for Hepatic Encephalopathy

5 results

  • Generlac (lactulose)

    (Lactulose)
    Chartwell RX, LLC
    Usage: Lactulose solution is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels, improving mental state and EEG patterns, with a satisfactory clinical response in approximately 75% of patients. Additionally, it often enhances protein tolerance.

  • Humatin (paromomycin sulfate)

    (PAROMOMYCIN SULFATE)
    Waylis Therapeutics LLC
    Usage: Paromomycin sulfate is indicated for treating acute and chronic intestinal amebiasis and as adjunctive therapy in managing hepatic coma. It should be used to treat or prevent infections caused by susceptible bacteria to avoid drug resistance.

  • Lactulose (lactulose)

    (Lactulose)
    APOZEAL PHARMACEUTICALS INC
    Usage: Lactulose is indicated for preventing and treating portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels and improves mental state in about 75% of patients, enhancing protein tolerance, and has shown efficacy in long-term use.

  • Neomycin sulfate (neomycin sulfate)

    (Neomycin Sulfate)
    XGen Pharmaceuticals DJB, Inc.
    Usage: Neomycin Sulfate Tablets are indicated to prevent drug-resistant bacteria by treating infections caused by susceptible bacteria, suppressing intestinal flora for bowel preparation, and as adjunctive therapy in hepatic coma to reduce ammonia-forming bacteria, improving neurologic symptoms.

  • Xifaxan

    (rifaximin)
    Salix Pharmaceuticals, Inc.
    Usage: XIFAXAN is indicated for treating travelers’ diarrhea caused by noninvasive E. coli, reducing recurrent overt hepatic encephalopathy in adults, and treating irritable bowel syndrome with diarrhea in adults. It should only be used for infections proven or strongly suspected to be caused by susceptible bacteria to prevent resistance.